755 (Temozolomide 180 mg)
Pill with imprint 755 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 755
Temozolomide
- Imprint
- 755
- Strength
- 180 mg
- Color
- Orange & White
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0755
- Inactive Ingredients
-
alcohol,
ammonia,
lactose anhydrous,
butyl alcohol,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
gelatin,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type B potato,
stearic acid,
tartaric acid,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "755"
More about temozolomide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (8)
- Drug images
- Pricing & coupons
- En español
- Drug class: alkylating agents
Patient resources
- Drug Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.